Literature DB >> 20584926

The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response.

Pan Chen1, Alexander J Burdette, J Christopher Porter, John C Ricketts, Stacey A Fox, Flavia C Nery, Jeffrey W Hewett, Laura A Berkowitz, Xandra O Breakefield, Kim A Caldwell, Guy A Caldwell.   

Abstract

Early-onset torsion dystonia is the most severe heritable form of dystonia, a human movement disorder that typically starts during a developmental window in early adolescence. Deletion in the DYT1 gene, encoding the torsinA protein, is responsible for this dominantly inherited disorder, which is non-degenerative and exhibits reduced penetrance among carriers. Here, we explore the hypothesis that deficits in torsinA function result in an increased vulnerability to stress associated with protein folding and processing in the endoplasmic reticulum (ER), where torsinA is located. Using an in vivo quantitative readout for the ER stress response, we evaluated the consequences of torsinA mutations in transgenic nematodes expressing variants of human torsinA. This analysis revealed that, normally, torsinA serves a protective function to maintain a homeostatic threshold against ER stress. Furthermore, we show that the buffering capacity of torsinA is greatly diminished by the DYT1-associated deletion or mutations that prevent its translocation to the ER, block ATPase activity, or increase the levels of torsinA in the nuclear envelope versus ER. Combinations of transgenic Caenorhabditis elegans designed to mimic clinically relevant genetic modifiers of disease susceptibility also exhibit a direct functional correlation to changes in the ER stress response. Furthermore, using mouse embryonic fibroblasts (MEFs) from torsinA knockout mice, we demonstrated that loss of endogenous torsinA results in enhanced sensitivity to ER stress. This study extends our understanding of molecular mechanisms underlying dystonia, and establishes a new functional paradigm to evaluate therapeutic strategies to compensate for reduced torsinA activity in the ER as a means to restore homeostatic balance and neuronal function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584926      PMCID: PMC2928126          DOI: 10.1093/hmg/ddq266

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  61 in total

Review 1.  Principles of protein folding, misfolding and aggregation.

Authors:  Christopher M Dobson
Journal:  Semin Cell Dev Biol       Date:  2004-02       Impact factor: 7.727

2.  Development and anatomic localization of torsinA.

Authors:  Shelley R Oberlin; Marina Konakova; Stefan Pulst; Marie-Françoise Chesselet
Journal:  Adv Neurol       Date:  2004

3.  TorsinA, the gene linked to early-onset dystonia, is upregulated by the dopaminergic toxin MPTP in mice.

Authors:  Rohini Kuner; Peter Teismann; Annette Trutzel; Jomana Naim; Angelika Richter; Nicole Schmidt; Alfred Bach; Boris Ferger; Armin Schneider
Journal:  Neurosci Lett       Date:  2004-01-23       Impact factor: 3.046

4.  Characterization of human torsinA and its dystonia-associated mutant form.

Authors:  Zhonghua Liu; Anna Zolkiewska; Michal Zolkiewski
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

5.  TorsinA in the nuclear envelope.

Authors:  Teresa V Naismith; John E Heuser; Xandra O Breakefield; Phyllis I Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

6.  Developmental expression of rat torsinA transcript and protein.

Authors:  Jianfeng Xiao; Suzhen Gong; Yu Zhao; Mark S LeDoux
Journal:  Brain Res Dev Brain Res       Date:  2004-08-18

7.  Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors.

Authors:  D C Bragg; S M Camp; C A Kaufman; J D Wilbur; H Boston; D E Schuback; P I Hanson; M Sena-Esteves; X O Breakefield
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

8.  Overexpression of torsinA in PC12 cells protects against toxicity.

Authors:  P Shashidharan; Nicolae Paris; Daniela Sandu; Laina Karthikeyan; Kevin St P McNaught; Ruth H Walker; C Warren Olanow
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

9.  Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.

Authors:  Rose E Goodchild; William T Dauer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-07       Impact factor: 11.205

10.  Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.

Authors:  Pedro Gonzalez-Alegre; Henry L Paulson
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

View more
  54 in total

Review 1.  A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders.

Authors:  Paige M Dexter; Kim A Caldwell; Guy A Caldwell
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 2.  Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

Authors:  Henry A Lester; Julie M Miwa; Rahul Srinivasan
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

Review 3.  Torsins: not your typical AAA+ ATPases.

Authors:  April E Rose; Rebecca S H Brown; Christian Schlieker
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-13       Impact factor: 8.250

Review 4.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 5.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

6.  TorsinA dysfunction causes persistent neuronal nuclear pore defects.

Authors:  Samuel S Pappas; Chun-Chi Liang; Sumin Kim; CheyAnne O Rivera; William T Dauer
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

Review 7.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

8.  SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity.

Authors:  Dinorah Leyva-Illades; Pan Chen; Charles E Zogzas; Steven Hutchens; Jonathan M Mercado; Caleb D Swaim; Richard A Morrisett; Aaron B Bowman; Michael Aschner; Somshuvra Mukhopadhyay
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

9.  Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.

Authors:  Jasmin Hettich; Scott D Ryan; Osmar Norberto de Souza; Luís Fernando Saraiva Macedo Timmers; Shelun Tsai; Nadia A Atai; Cintia C da Hora; Xuan Zhang; Rashmi Kothary; Erik Snapp; Maria Ericsson; Kathrin Grundmann; Xandra O Breakefield; Flávia C Nery
Journal:  Hum Mutat       Date:  2014-07-17       Impact factor: 4.878

10.  TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration.

Authors:  Chun-Chi Liang; Lauren M Tanabe; Stephanie Jou; Frank Chi; William T Dauer
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.